FDA Cybersecurity Capabilities Projects IDIQ   3

AMENDMENT 1

The following new attachments are incorporated for amendment 1

• Responses to the questions received.
• Amended Attachment B - IDIQ Statement of Work. Removed "Not to Compete" section.

All other terms and conditions remain unchanged and in full effect.

------

This is a solicitation for the U.S. Food and Drug Administration's requirement for:
Cybersecurity Capabilities Projects Indefinite Delivery Indefinite Quantity (IDIQ)

This requirement is being solicited as a competitive 8(a) set-aside; only those companies certified by the U.S. Small Business Administration as an 8(a) busines that have not graduated from the program are eligible for award. The associated North American Industry Classification System Code (NAICS) is 541512 Computer Systems Design Services with a small business size standard of $30 million.

The U.S. Food and Drug Administration (FDA) intends to award only one (1) Indefinite Delivery Indefinite Quantity (IDIQ) contract resulting from this solicitation.

For the purpose of this solicitation, the FDA intends to conduct the evaluation and selection process in TWO (2) PHASES.

• PHASE I - Request for Qualifications
• PHASE II - Request for Proposal

All responsible sources may submit a proposal, which if timely received, will be considered.

It is the offeror's reponsiblity to carefully review form SF-1449 and all attachments before responding to the solicitation.

Attached to the solicitation posting are the following documents:

• Standard Form 1449 (SF1449)
• Attachment A Pricing Workbook and Labor Categories
• Attachment B IDIQ Statement of Work (SOW), FDA Cybersecurity Capabilities Projects
• Attachment C Task Order #1 FDA OIMT-OIS Risk and Vulnerability Assessment SOW
• Attachment D Task Order #2 FDA Cybersecurity Support Services SOW
• Attachment E Evaluation Instructions and Criteria
• Attachment F Past Performance Questionnaire (for Phase II)